Insider Trading April 28, 2026 06:22 PM

Cannae Holdings Executive Disposes of IRA Shares Amid Recent Earnings Miss and Buyback Expansion

EVP Peter Sadowski completes a minor share sale as the company navigates recent revenue and EPS shortfalls.

By Caleb Monroe CNNE
Cannae Holdings Executive Disposes of IRA Shares Amid Recent Earnings Miss and Buyback Expansion
CNNE

Peter T. Sadowski, who serves as the Executive Vice President and Chief Legal Officer for Cannae Holdings, Inc. (NASDAQ: CNNE), has executed a transaction involving the sale of company stock. The disposal, which took place on April 8, 2026, involved shares held within his Peter Sadowski IRA. This move comes at a time when Cannae Holdings is managing recent financial reporting outcomes and an expanded share repurchase initiative.

Key Points

  • Executive Peter Sadowski sold 157 shares from his IRA at $12.25 per share on April 8, 2026.
  • Cannae Holdings has expanded its total stock repurchase authorization to 14.9 million shares.
  • The company's Q4 2025 earnings showed a major EPS miss of 543.33% relative to forecasts.

According to recent regulatory filings via Form 4, Peter T. Sadowski, the Executive Vice President and Chief Legal Officer at Cannae Holdings, Inc. (NASDAQ: CNNE), sold a portion of his holdings in the company. The transaction involved the sale of 157 shares that were held under the Peter Sadowski IRA. These shares were liquidated at a price point of $12.25 per share, resulting in total proceeds of $1,923. Following this specific disposal, the Peter Sadowski IRA no longer maintains any position in the company's stock.


Despite the sale occurring at $12.25, the market has seen movement in the ticker since that time. The stock has experienced a 6% increase over the past week, reaching a price of $13.60. Cannae Holdings currently maintains a market capitalization of $628 million and provides a dividend yield of 4.41%. Regarding Mr. Sadowski's remaining interests, he continues to hold 101,471 shares of Cannae Holdings common stock directly. Furthermore, an additional 53,640 shares are held through the Sadowski Living Trust.


Key Market Observations

The recent activity at Cannae Holdings highlights several critical data points for market observers:

  • Executive Stock Movement: The liquidation of the IRA position by a top executive, while small in dollar value, is a notable component of internal transaction tracking.
  • Capital Allocation Strategy: The company has actively engaged in shareholder return strategies through its board-authorized stock repurchase program. This includes a new authorization for up to 10 million shares of common stock. When combined with the 4.9 million shares remaining from previous authorizations, the total buyback capacity stands at 14.9 million shares against 46.4 million shares currently outstanding.
  • Financial Performance Context: Recent quarterly data indicates a period of volatility in meeting expectations. For the fourth quarter of 2025, Cannae Holdings reported revenue of $103.3 million, missing the anticipated $104.8 million by 1.43%.

Risks and Uncertainties

Investors monitoring CNNE should account for several explicit financial risks noted in recent reporting:

  • Earnings Volatility: The company reported a significant discrepancy in earnings per share (EPS) for the fourth quarter of 2025. While analysts expected an EPS of -$0.30, the actual reported figure was -$1.93, representing a negative surprise of 543.33%.
  • Valuation Discrepancies: Analysis indicates that the stock may currently be trading at a level slightly above its estimated Fair Value, suggesting potential overvaluation in the current market environment.

These factors combined provide a complex view of the company's current fiscal standing and internal management movements.

Risks

  • Significant negative surprise in EPS during the fourth quarter of 2025.
  • Potential stock overvaluation relative to calculated Fair Value.
  • Revenue shortfalls compared to projected quarterly expectations.

More from Insider Trading

Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026 Mitek Systems COO Executes Tax-Related Share Sale Amid Recent Performance Milestones Apr 28, 2026 Porch Group COO Executes Tax-Related Stock Sale Amid Mixed Quarterly Results Apr 28, 2026